Search results
Pfizer 'can't rule out' layoffs in North Carolina after gene therapy flub - Triangle Business...
The Business Journals· 1 hour agoLayoffs could by on the way at Pfizer's massive facility in Sanford after the company's gene therapy...
The 'Impressive' Results That Sent Top 1% Avidity Biosciences To A Record
Investor's Business Daily· 6 days agoAvidity Biosciences unveiled "impressive" results from a study of its treatment for a rare form of ...
Pfizer Failure in Duchenne Muscular Dystrophy Trial Leaves Field Open
Barrons.com· 5 days agoThe drug company Pfizer said a gene therapy it is testing failed to improve motor function in boys...
FDA approves generic Emflaza oral suspension for Duchenne muscular dystrophy
Medical Xpress· 1 day agoThe U.S. Food and Drug Administration has approved the first generic version of Emflaza...
Avidity drug for muscular dystrophy shows promise; Syntis takes new approach to weight loss
BioPharma Dive via Yahoo Finance· 6 days agoStudy results indicated Avidity’s medicine muted target genes. Elsewhere, Syntis revealed obesity...
$10,000 for 10 years: Chesterfield-based organization helping those with neuromuscular disorders
WRIC 8 News Richmond· 6 days agoFor ten years, the Colorado Fund for Muscular Dystrophy (CMFD) has been working to improve the lives...
Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with...
Morningstar· 6 days agoThe primary endpoint in the final analysis was assessed by change in the North Star Ambulatory...
Study finds LED therapy and antioxidant drug benefit muscle regeneration in Duchenne muscular ...
Medical Xpress· 4 days agoAs reported in an article published in the journal PLOS ONE, the strategy prevented muscle...
Early data for Avidity's RNA therapy show possible functional benefit in muscular dystrophy
FierceBiotech· 6 days agoAvidity Biosciences’ AOC 1020, newly dubbed del-brax, demonstrated a safe profile and was tied to...
Sarepta’s stock gains after Pfizer’s Duchenne trial failure - Boston Business Journal
The Business Journals· 5 days agoSarepta Therapeutics, a Cambridge drugmaker known for its Duchenne muscular dystrophy treatments,...